Cargando…
Molecular diagnostic testing of diffuse gliomas in the real-life setting: A practical approach
Typing of diffuse gliomas according to the WHO 2016 Classification of Tumors of the Central Nervous System is based on the integration of histology with molecular biomarkers. However, the choice of appropriate methods for molecular analysis and criteria for interpretation of test results is left to...
Autores principales: | Bieńkowski, Michał, Wöhrer, Adelheid, Moser, Patrizia, Kitzwögerer, Melitta, Ricken, Gerda, Ströbel, Thomas, Hainfellner, Johannes A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102559/ https://www.ncbi.nlm.nih.gov/pubmed/29923492 http://dx.doi.org/10.5414/NP301110 |
Ejemplares similares
-
Clinical Neuropathology practice guide 5-2015: MGMT methylation pyrosequencing in glioblastoma: unresolved issues and open questions
por: Bienkowski, Michal, et al.
Publicado: (2015) -
Patterns of diagnostic marker assessment in adult diffuse glioma: a survey of the European Confederation of Neuropathological Societies (Euro-CNS)
por: Woehrer, Adelheid, et al.
Publicado: (2017) -
Mapping high-grade glioma immune infiltration to 5-ALA fluorescence levels: TCGA data computation, classical histology, and digital image analysis
por: Lang, Alexandra, et al.
Publicado: (2023) -
Clinical Neuropathology practice news 2-2014: ATRX, a new candidate biomarker in gliomas
por: Haberler, Christine, et al.
Publicado: (2014) -
Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables
por: Erhart, Friedrich, et al.
Publicado: (2018)